Skip to main content
Top
Published in: Drug Safety 2/2000

01-02-2000 | Review Article

Corticosteroid-Induced Adverse Psychiatric Effects

Incidence, Diagnosis and Management

Authors: Assistant Professor Scott B. Patten, C. Ineke Neutel

Published in: Drug Safety | Issue 2/2000

Login to get access

Abstract

Reports of corticosteroid-induced adverse psychiatric effects began to appear in the literature soon after the introduction of these medications in the 1950s. Unfortunately, early studies relied on informal classification and measurement procedures and tended to utilise nonspecific descriptive terminology (such as ‘steroid psychosis’). A growing number of contemporary investigations have begun to address these problems. However, the literature remains surprisingly undeveloped from a pharmacoepidemiological perspective, consisting largely of case reports and case series.
The objective of this review is to summarise published data concerning corticosteroid-induced adverse psychiatric effects. A clinical perspective will be adopted since opportunities to minimise the impact of corticosteroid-induced adverse effects tend to present themselves most readily within the sphere of clinical management.
Some of the psychiatric adverse effects of corticosteroids are mild, and not necessarily clinically significant. However, several serious psychiatric syndromes can be caused by corticosteroids: substance-induced mood disorders (with depressive, manic and mixed features), substance-induced psychotic disorders and delirium. While certain clinical groups may be at greater risk of corticosteroid-induced adverse psychiatric effects, corticosteroid-induced psychiatric toxicity is remarkably unpredictable.
The literature regarding prevention and treatment of corticosteroid-induced adverse psychiatric effects is poorly developed. As a result, the emphasis of this review is on clinical and epidemiological evidence linking specific adverse effects to corticosteroid medications. However, clinical reports do provide some practical guidance for prevention and treatment, and these are summarised as well. A variety of pharmacological strategies for treatment and prevention have been proposed. Education and support also appear to be important, and perhaps neglected, aspects of management.
Literature
1.
go back to reference Clark LD, Quarton GC, Cobb S, et al. Further observations on mental disturbances associated with cortisone and ACTH therapy. N Engl J Med 1953; 249: 178–83PubMedCrossRef Clark LD, Quarton GC, Cobb S, et al. Further observations on mental disturbances associated with cortisone and ACTH therapy. N Engl J Med 1953; 249: 178–83PubMedCrossRef
2.
go back to reference Clark LD, Bauer W, Cobb S. Preliminary observations on mental disturbances occurring in patients under therapy with cortisone and ACTH. N Engl J Med 1952; 246: 205–16PubMedCrossRef Clark LD, Bauer W, Cobb S. Preliminary observations on mental disturbances occurring in patients under therapy with cortisone and ACTH. N Engl J Med 1952; 246: 205–16PubMedCrossRef
3.
go back to reference Ritchie EA. Toxic psychosis under cortisone and corticotrophin. J Ment Sci 1956; 102: 830–7PubMed Ritchie EA. Toxic psychosis under cortisone and corticotrophin. J Ment Sci 1956; 102: 830–7PubMed
4.
go back to reference Goolker P, Schein J. Psychic effects of ACTH and cortisone. Psychosom Med 1953; 15: 589–613PubMed Goolker P, Schein J. Psychic effects of ACTH and cortisone. Psychosom Med 1953; 15: 589–613PubMed
5.
6.
go back to reference Conn HO, Poynard T. Corticosteroids and peptic ulcer: metaanalysis of adverse events during steroid therapy. J Intern Med 1994; 236: 619–32PubMedCrossRef Conn HO, Poynard T. Corticosteroids and peptic ulcer: metaanalysis of adverse events during steroid therapy. J Intern Med 1994; 236: 619–32PubMedCrossRef
7.
go back to reference Cohen SI. Cushing’s syndrome: a psychiatric study of 29 patients. Br J Psychiatry 1980; 136: 120–4PubMedCrossRef Cohen SI. Cushing’s syndrome: a psychiatric study of 29 patients. Br J Psychiatry 1980; 136: 120–4PubMedCrossRef
8.
go back to reference Starkman MN, Schteingart DE, Schork MA. Depressed mood and other psychiatric manifestations of Cushing’s syndrome: relationship to hormone levels. Psychosom Med 1981; 43(1): 3–18PubMed Starkman MN, Schteingart DE, Schork MA. Depressed mood and other psychiatric manifestations of Cushing’s syndrome: relationship to hormone levels. Psychosom Med 1981; 43(1): 3–18PubMed
9.
go back to reference Kelly WF, Checkley SA, Bender DA, et al. Cushing’s syndrome and depression - a prospective study of 26 patients. Br J Psychiatry 1983; 142: 16–9PubMedCrossRef Kelly WF, Checkley SA, Bender DA, et al. Cushing’s syndrome and depression - a prospective study of 26 patients. Br J Psychiatry 1983; 142: 16–9PubMedCrossRef
10.
go back to reference Kelly WF, Checkley SA, Bender DA. Cushing’s syndrome, tryptophan and depression. Br J Psychiatry 1980; 136: 125–32PubMedCrossRef Kelly WF, Checkley SA, Bender DA. Cushing’s syndrome, tryptophan and depression. Br J Psychiatry 1980; 136: 125–32PubMedCrossRef
11.
go back to reference Pies RP. Differential diagnosis and treatment of steroid-induced affective syndromes. Gen Hosp Psychiatry 1995; 17: 353–61PubMedCrossRef Pies RP. Differential diagnosis and treatment of steroid-induced affective syndromes. Gen Hosp Psychiatry 1995; 17: 353–61PubMedCrossRef
12.
go back to reference Rome HP, Braceland FJ. The psychological response to ACTH, cortisone, hydrocortisone, and related steroid substances. Am J Psychiatry 1952; 108: 641–51PubMed Rome HP, Braceland FJ. The psychological response to ACTH, cortisone, hydrocortisone, and related steroid substances. Am J Psychiatry 1952; 108: 641–51PubMed
13.
go back to reference Kershner P, Wang-Cheng R. Psychiatric side effects of steroid therapy. Psychosomatics 1989; 30(2): 135–9PubMedCrossRef Kershner P, Wang-Cheng R. Psychiatric side effects of steroid therapy. Psychosomatics 1989; 30(2): 135–9PubMedCrossRef
14.
go back to reference Silva RG, Tolstunov L. Steroid-induced psychosis: report of case. J Oral Maxillofac Surg 1995; 53: 183–6PubMedCrossRef Silva RG, Tolstunov L. Steroid-induced psychosis: report of case. J Oral Maxillofac Surg 1995; 53: 183–6PubMedCrossRef
15.
go back to reference Stoudemire A, Anfinson T, Edwards J. Corticosteroid-induced delirium and dependency. Gen Hosp Psychiatry 1996; 18: 196–202PubMedCrossRef Stoudemire A, Anfinson T, Edwards J. Corticosteroid-induced delirium and dependency. Gen Hosp Psychiatry 1996; 18: 196–202PubMedCrossRef
16.
go back to reference Stiefel FC, Breitbart WS, Holland JC. Corticosteroids in cancer: neuropsychiatric complications. Cancer Invest 1989; 7: 479–91PubMedCrossRef Stiefel FC, Breitbart WS, Holland JC. Corticosteroids in cancer: neuropsychiatric complications. Cancer Invest 1989; 7: 479–91PubMedCrossRef
17.
go back to reference American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association, 1994 American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association, 1994
18.
go back to reference Mullen RS, Romans-Clarkson SE. Behavioural sensitisation and steroid-induced psychosis. Br J Psychiatry 1993; 162: 549–51PubMedCrossRef Mullen RS, Romans-Clarkson SE. Behavioural sensitisation and steroid-induced psychosis. Br J Psychiatry 1993; 162: 549–51PubMedCrossRef
19.
go back to reference Greeves JA. Rapid-onset steroid psychosis with very low dosage of prednisolone [letter]. Lancet 1984; I: 1119–20CrossRef Greeves JA. Rapid-onset steroid psychosis with very low dosage of prednisolone [letter]. Lancet 1984; I: 1119–20CrossRef
20.
go back to reference Gift AG, Wood RM, Cahill CA. Depression, somatization and steroid use in chronic obstructive pulmonary disease. Int J Nurs Stud 1989; 26: 281–6PubMedCrossRef Gift AG, Wood RM, Cahill CA. Depression, somatization and steroid use in chronic obstructive pulmonary disease. Int J Nurs Stud 1989; 26: 281–6PubMedCrossRef
21.
go back to reference Patten SB, Williams JVA, Love EJ. Self-reported depressive symptoms in association with medication exposures among medical inpatients: a cross-sectional study. Can J Psychiatry 1995; 40: 264–9PubMed Patten SB, Williams JVA, Love EJ. Self-reported depressive symptoms in association with medication exposures among medical inpatients: a cross-sectional study. Can J Psychiatry 1995; 40: 264–9PubMed
22.
go back to reference Palinkas LA, Wingard DL, Barrett-Connor E. Chronic illness and depressive symptoms in the elderly: a population-based study. J Clin Epidemiol 1990; 43(11): 1131–41PubMedCrossRef Palinkas LA, Wingard DL, Barrett-Connor E. Chronic illness and depressive symptoms in the elderly: a population-based study. J Clin Epidemiol 1990; 43(11): 1131–41PubMedCrossRef
23.
go back to reference Patten SB, Williams JVA, Love EJ. Self-reported depressive symptoms following treatment with corticosteroids and sedative-hypnotics. Int J Psychiatry Med 1996; 26(1): 15–24PubMedCrossRef Patten SB, Williams JVA, Love EJ. Self-reported depressive symptoms following treatment with corticosteroids and sedative-hypnotics. Int J Psychiatry Med 1996; 26(1): 15–24PubMedCrossRef
24.
go back to reference Patten SB, Williams JVA, Love EJ. A case-control study of corticosteroid exposure as a risk factor for clinically-diagnosed depressive disorders in a hospitalized population. Can J Psychiatry 1995; 40: 396–400PubMed Patten SB, Williams JVA, Love EJ. A case-control study of corticosteroid exposure as a risk factor for clinically-diagnosed depressive disorders in a hospitalized population. Can J Psychiatry 1995; 40: 396–400PubMed
25.
go back to reference Arana GW, Santos AB, Laraia MT, et al. Dexamethasone for the treatment of depression: a randomized, placebo-controlled, double-blind study. Am J Psychiatry 1995; 152: 265–7PubMed Arana GW, Santos AB, Laraia MT, et al. Dexamethasone for the treatment of depression: a randomized, placebo-controlled, double-blind study. Am J Psychiatry 1995; 152: 265–7PubMed
26.
go back to reference Soffer LJ, Levitt MF, Baehr G. Use of cortisone and adrenocorticotropic hormone in acute disseminated lupus erythematosus. Arch Intern Med 1950; 86: 558–73CrossRef Soffer LJ, Levitt MF, Baehr G. Use of cortisone and adrenocorticotropic hormone in acute disseminated lupus erythematosus. Arch Intern Med 1950; 86: 558–73CrossRef
27.
go back to reference Terao T, Mizuki T, Ohji T, et al. Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroids. Br J Psychiatry 1994; 164: 109–11PubMedCrossRef Terao T, Mizuki T, Ohji T, et al. Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroids. Br J Psychiatry 1994; 164: 109–11PubMedCrossRef
28.
go back to reference Baker M, Hadler NM, Whitaker JN, et al. Psychopathology in systemic lupus erythematosus: II: relation to clinical observations, corticosteroid administration, and cerebrospinal fluid C4. Semin Arthritis Rheum 1973; 3: 111–26PubMedCrossRef Baker M, Hadler NM, Whitaker JN, et al. Psychopathology in systemic lupus erythematosus: II: relation to clinical observations, corticosteroid administration, and cerebrospinal fluid C4. Semin Arthritis Rheum 1973; 3: 111–26PubMedCrossRef
29.
go back to reference Jones BD, Chouinard G. Clonazepam in the treatment of recurrent symptoms of depression and anxiety in a patient with systemic lupus erythematosus. Am J Psychiatry 1985; 142: 354–5PubMed Jones BD, Chouinard G. Clonazepam in the treatment of recurrent symptoms of depression and anxiety in a patient with systemic lupus erythematosus. Am J Psychiatry 1985; 142: 354–5PubMed
30.
go back to reference Naber D, Sand P, Heigl B. Psychopathological and neuropsychological effects of 8-days’ corticosteroid treatment: a prospective study. Psychoneuroendocrinology 1996; 21: 25–31PubMedCrossRef Naber D, Sand P, Heigl B. Psychopathological and neuropsychological effects of 8-days’ corticosteroid treatment: a prospective study. Psychoneuroendocrinology 1996; 21: 25–31PubMedCrossRef
31.
go back to reference Rundell JR, Wise MG. Causes of organic mood disorder. J Neuropsychiatry Clin Neurosci 1989; 1: 398–400PubMed Rundell JR, Wise MG. Causes of organic mood disorder. J Neuropsychiatry Clin Neurosci 1989; 1: 398–400PubMed
32.
go back to reference Sharfstein SS, Sack DS, Fauci AS. Relationship between alternate-day corticosteroid therapy and behavioral abnormalities. JAMA 1982; 248: 2987–9PubMedCrossRef Sharfstein SS, Sack DS, Fauci AS. Relationship between alternate-day corticosteroid therapy and behavioral abnormalities. JAMA 1982; 248: 2987–9PubMedCrossRef
33.
go back to reference Joffe RT, Denicoff KD, Rubinow DR, et al. Mood effects of alternate-day corticosteroid therapy in patients with systemic lupus erythematosus. Gen Hosp Psychiatry 1988; 10: 56–60PubMedCrossRef Joffe RT, Denicoff KD, Rubinow DR, et al. Mood effects of alternate-day corticosteroid therapy in patients with systemic lupus erythematosus. Gen Hosp Psychiatry 1988; 10: 56–60PubMedCrossRef
34.
go back to reference Minden SL, Orav J, Schildkraut JJ. Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology 1988; 38: 1631–4PubMedCrossRef Minden SL, Orav J, Schildkraut JJ. Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology 1988; 38: 1631–4PubMedCrossRef
35.
go back to reference Fishman SM, Catarau EM, Sachs GM, et al. Corticosteroid-induced mania after single regional application at the celiac plexus. Anesthiology 1996; 85: 1194–6CrossRef Fishman SM, Catarau EM, Sachs GM, et al. Corticosteroid-induced mania after single regional application at the celiac plexus. Anesthiology 1996; 85: 1194–6CrossRef
37.
go back to reference Meyboom RH. Budesonide and psychic side effects [letter]. Ann Intern Med 1988; 109: 683PubMed Meyboom RH. Budesonide and psychic side effects [letter]. Ann Intern Med 1988; 109: 683PubMed
38.
go back to reference Lewis LD, Cochrane GM. Psychosis in a child inhaling budesonide [letter]. Lancet 1983; II: 634CrossRef Lewis LD, Cochrane GM. Psychosis in a child inhaling budesonide [letter]. Lancet 1983; II: 634CrossRef
39.
40.
go back to reference Bell G. Steroid-induced psychiatric disorders. Nord Psykiatr Tidsskr 1991; 45: 437–41CrossRef Bell G. Steroid-induced psychiatric disorders. Nord Psykiatr Tidsskr 1991; 45: 437–41CrossRef
41.
go back to reference Hall RCW, Popkin MK, Stickney SK, et al. Presentation of the steroid psychoses. J Nerv Ment Dis 1979; 167`(4): 229–36 Hall RCW, Popkin MK, Stickney SK, et al. Presentation of the steroid psychoses. J Nerv Ment Dis 1979; 167`(4): 229–36
43.
go back to reference Yunus MB, Morgan RJ, Barclay AM, et al. Organic brain syndrome in rheumatoid arthritis after corticosteroid withdrawal [letter]. J Rheumatol 1985; 12: 636–7PubMed Yunus MB, Morgan RJ, Barclay AM, et al. Organic brain syndrome in rheumatoid arthritis after corticosteroid withdrawal [letter]. J Rheumatol 1985; 12: 636–7PubMed
44.
go back to reference Perenyi A, Frecska E, Badgy G, et al. Panic attacks as a consequence of chronic corticosteroid therapy? Eur J Psychiatry 1988; 2: 69–74 Perenyi A, Frecska E, Badgy G, et al. Panic attacks as a consequence of chronic corticosteroid therapy? Eur J Psychiatry 1988; 2: 69–74
45.
go back to reference Wyszynski AA, Wyszynski B. Treatment of depression with fluoxetine in corticosteroid-dependent central nervous system Sjogren’s syndrome. Psychosomatics 1993; 34(2): 173–7PubMedCrossRef Wyszynski AA, Wyszynski B. Treatment of depression with fluoxetine in corticosteroid-dependent central nervous system Sjogren’s syndrome. Psychosomatics 1993; 34(2): 173–7PubMedCrossRef
46.
go back to reference Cade R, Spooner G, Schlein E, et al. Comparison of azothioprine, prednisone, and heparin alone or combined in treating lupus nephritis. Nephron 1973; 10: 37–56PubMedCrossRef Cade R, Spooner G, Schlein E, et al. Comparison of azothioprine, prednisone, and heparin alone or combined in treating lupus nephritis. Nephron 1973; 10: 37–56PubMedCrossRef
47.
go back to reference Wysenbeek AJ, Leibovici L, Zoldan J. Acute central nervous system complications after pulse steroid therapy in patients with systemic lupus erythematosus. J Rheumatol 1990; 17: 1695–6PubMed Wysenbeek AJ, Leibovici L, Zoldan J. Acute central nervous system complications after pulse steroid therapy in patients with systemic lupus erythematosus. J Rheumatol 1990; 17: 1695–6PubMed
48.
go back to reference Marx FW, Barker WF. Surgical results in patients with ulcerative colitis treated with and without corticosteroids. Am J Surg 1967; 113: 157–63PubMedCrossRef Marx FW, Barker WF. Surgical results in patients with ulcerative colitis treated with and without corticosteroids. Am J Surg 1967; 113: 157–63PubMedCrossRef
49.
go back to reference Turktas I, Gucuyener K, Ozden A. Medication-induced psychotic reaction [letter]. J Am Acad Child Adolesc Psychiatry 1997; 36: 1017–8PubMedCrossRef Turktas I, Gucuyener K, Ozden A. Medication-induced psychotic reaction [letter]. J Am Acad Child Adolesc Psychiatry 1997; 36: 1017–8PubMedCrossRef
50.
go back to reference Walkowitz OM. Prospective controlled studies of the behavioural and biological effects of exogenous corticosteroids. Psychoneuroendocrinology 1994; 19: 233–55CrossRef Walkowitz OM. Prospective controlled studies of the behavioural and biological effects of exogenous corticosteroids. Psychoneuroendocrinology 1994; 19: 233–55CrossRef
51.
go back to reference Lidz T, Carter JD, Lewis BI, et al. Effects of ACTH and cortisone on mood and mentation. Psychosom Med 1952; 24: 363–77 Lidz T, Carter JD, Lewis BI, et al. Effects of ACTH and cortisone on mood and mentation. Psychosom Med 1952; 24: 363–77
52.
go back to reference Cameron OG, Addy RO, Malitz D. Effects of ACTH and prednisone on mood: incidence and time of onset. Int J Psychiatry Med 1985; 15: 213–23PubMedCrossRef Cameron OG, Addy RO, Malitz D. Effects of ACTH and prednisone on mood: incidence and time of onset. Int J Psychiatry Med 1985; 15: 213–23PubMedCrossRef
53.
go back to reference Swinburn CR, Wakefield JM, Newman SP, et al. Evidence of prednisolone induced mood change (‘steroid euphoria’) in patients with chronic obstructive airways disease. Br J Clin Pharmacol 1988; 26: 709–13PubMedCrossRef Swinburn CR, Wakefield JM, Newman SP, et al. Evidence of prednisolone induced mood change (‘steroid euphoria’) in patients with chronic obstructive airways disease. Br J Clin Pharmacol 1988; 26: 709–13PubMedCrossRef
55.
go back to reference Kimball CP. Psychological dependency on steroids? Ann Intern Med 1971; 75: 111–3PubMed Kimball CP. Psychological dependency on steroids? Ann Intern Med 1971; 75: 111–3PubMed
56.
go back to reference Brown ES. Chemical dependence involving glucocorticoids. Ann Clin Pschiatry 1997; 9: 185–7 Brown ES. Chemical dependence involving glucocorticoids. Ann Clin Pschiatry 1997; 9: 185–7
57.
go back to reference Grigg JR. Prednisone mood disorder with associated catatonia. J Geriatr Psychiatry Neurol 1989; 2: 41–4PubMedCrossRef Grigg JR. Prednisone mood disorder with associated catatonia. J Geriatr Psychiatry Neurol 1989; 2: 41–4PubMedCrossRef
58.
go back to reference Sullivan BJ, Dickerman JD. Steroid-associated catatonia: report of a case. Pediatrics 1979; 63: 677–9PubMed Sullivan BJ, Dickerman JD. Steroid-associated catatonia: report of a case. Pediatrics 1979; 63: 677–9PubMed
59.
go back to reference Varney NR, Alexander B, MacIndoe JH. Reversible steroid dementia in patients without steroid psychosis. Am J Psychiatry 1994; 141: 369–72 Varney NR, Alexander B, MacIndoe JH. Reversible steroid dementia in patients without steroid psychosis. Am J Psychiatry 1994; 141: 369–72
60.
go back to reference Suess WM, Stump N, Chai H, et al. Mnemonic effects of asthma medication in children. J Asthma 1986; 23: 291–6PubMedCrossRef Suess WM, Stump N, Chai H, et al. Mnemonic effects of asthma medication in children. J Asthma 1986; 23: 291–6PubMedCrossRef
61.
go back to reference Bender BG, Lerner JA, Kollasch E. Mood and memory changes in asthmatic children receiving corticosteroids. J Am Acad Child Adolesc Psychiatry 1988; 27: 720–5PubMedCrossRef Bender BG, Lerner JA, Kollasch E. Mood and memory changes in asthmatic children receiving corticosteroids. J Am Acad Child Adolesc Psychiatry 1988; 27: 720–5PubMedCrossRef
62.
go back to reference Arnold LE. Increased arousal from steroids? J Am Acad Child Adolesc Psychiatry 1989; 28: 618–9 Arnold LE. Increased arousal from steroids? J Am Acad Child Adolesc Psychiatry 1989; 28: 618–9
63.
go back to reference Bender BG. Drs Bender and Lerner reply. J Am Acad Child Adolesc Psychiatry 1989; 28: 619CrossRef Bender BG. Drs Bender and Lerner reply. J Am Acad Child Adolesc Psychiatry 1989; 28: 619CrossRef
64.
go back to reference Hall RCW, Popkin MK, Kirkpatrick B. Tricyclic exacerbation of steroid psychosis. J Nerv Ment Dis 1978; 166: 738–42PubMedCrossRef Hall RCW, Popkin MK, Kirkpatrick B. Tricyclic exacerbation of steroid psychosis. J Nerv Ment Dis 1978; 166: 738–42PubMedCrossRef
65.
go back to reference Wolkowitz OM, Reus VI, Weingartner H, et al. Cognitive effects of corticosteroids. Am J Psychiatry 1990; 147: 1297–303PubMed Wolkowitz OM, Reus VI, Weingartner H, et al. Cognitive effects of corticosteroids. Am J Psychiatry 1990; 147: 1297–303PubMed
66.
go back to reference Newcomer JW, Craft S, Hershey T, et al. Glucocorticoid-induced impairments in declarative memory performance in adult humans. J Neurosci 1994; 14: 2047–53PubMed Newcomer JW, Craft S, Hershey T, et al. Glucocorticoid-induced impairments in declarative memory performance in adult humans. J Neurosci 1994; 14: 2047–53PubMed
67.
go back to reference Connett G, Lenney W. Inhaled budesonide and behavioural disturbances [letter]. Lancet 1991; 338: 636–5CrossRef Connett G, Lenney W. Inhaled budesonide and behavioural disturbances [letter]. Lancet 1991; 338: 636–5CrossRef
68.
go back to reference Harris JC, Carel CA, Rosenberg LA, et al. Intermittent high dose corticosteroid treatment in childhood cancer: behavioral and emotional consequences. J Am Acad Child Adolesc Psychiatry 1986; 1: 120–4 Harris JC, Carel CA, Rosenberg LA, et al. Intermittent high dose corticosteroid treatment in childhood cancer: behavioral and emotional consequences. J Am Acad Child Adolesc Psychiatry 1986; 1: 120–4
69.
go back to reference Hassanyeh F, Murray RB, Rodgers H. Adrenocortical suppression presenting with agitated depression, morbid jealousy, and a dementia-like state. Br J Psychiatry 1991; 159: 870–2PubMedCrossRef Hassanyeh F, Murray RB, Rodgers H. Adrenocortical suppression presenting with agitated depression, morbid jealousy, and a dementia-like state. Br J Psychiatry 1991; 159: 870–2PubMedCrossRef
70.
go back to reference Kreus KE, Viljanen AA, Kujula E, et al. Treatment of steroid-dependent asthma patients with beclomethasone dipropionate aerosol. Scand J Respir Med 1975; 56: 47–57 Kreus KE, Viljanen AA, Kujula E, et al. Treatment of steroid-dependent asthma patients with beclomethasone dipropionate aerosol. Scand J Respir Med 1975; 56: 47–57
71.
go back to reference Lewis A, Fleminger JJ. The psychiatric risk from corticotrophin and cortisone. Lancet 1954; I: 383–6CrossRef Lewis A, Fleminger JJ. The psychiatric risk from corticotrophin and cortisone. Lancet 1954; I: 383–6CrossRef
72.
go back to reference Vincent FM. The neuropsychiatric complications of corticosteroid therapy. Compr Ther 1995; 21: 524–8PubMed Vincent FM. The neuropsychiatric complications of corticosteroid therapy. Compr Ther 1995; 21: 524–8PubMed
73.
go back to reference Goggans FC, Weisberg LJ, Koran LM. Lithium prophylaxis of prednisone psychosis: a case report. J Clin Psychiatry 1983; 44: 111–2PubMed Goggans FC, Weisberg LJ, Koran LM. Lithium prophylaxis of prednisone psychosis: a case report. J Clin Psychiatry 1983; 44: 111–2PubMed
74.
go back to reference Frey BM, Frey FJ. Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet 1990; 19: 126–46PubMedCrossRef Frey BM, Frey FJ. Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet 1990; 19: 126–46PubMedCrossRef
75.
go back to reference Lewis DA, Smith RE. Steroid-induced psychiatric syndromes: a report of 14 cases and a review of the literature. J Affect Disord 1983; 5: 319–32PubMedCrossRef Lewis DA, Smith RE. Steroid-induced psychiatric syndromes: a report of 14 cases and a review of the literature. J Affect Disord 1983; 5: 319–32PubMedCrossRef
76.
go back to reference Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996; 276(4): 293–9PubMedCrossRef Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996; 276(4): 293–9PubMedCrossRef
77.
go back to reference Boston Collaborative Drug Surveillance Program. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 1972; 13: 694–8 Boston Collaborative Drug Surveillance Program. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 1972; 13: 694–8
78.
go back to reference Olsen EA, Carson SC, Turney EA. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch Dermatol 1992; 128: 1467–73PubMedCrossRef Olsen EA, Carson SC, Turney EA. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch Dermatol 1992; 128: 1467–73PubMedCrossRef
79.
go back to reference Glynne-Jones R, Vernon CC, Bell G. Is steroid psychosis preventable by divided doses [letter]. Lancet 1986; II: 1404CrossRef Glynne-Jones R, Vernon CC, Bell G. Is steroid psychosis preventable by divided doses [letter]. Lancet 1986; II: 1404CrossRef
80.
go back to reference Cordess C, Folstein M, Drachman D. Psychiatric effects of alternate day steroid therapy. Br J Psychiatry 1981; 138: 504–6PubMedCrossRef Cordess C, Folstein M, Drachman D. Psychiatric effects of alternate day steroid therapy. Br J Psychiatry 1981; 138: 504–6PubMedCrossRef
81.
go back to reference Finkenbine R, Gill HS. Case of mania due to prednisone-clarithromycin interaction [letter]. Can J Psychiatry 1997; 42: 778PubMed Finkenbine R, Gill HS. Case of mania due to prednisone-clarithromycin interaction [letter]. Can J Psychiatry 1997; 42: 778PubMed
82.
go back to reference Falk WE, Mahnke MW, Poskanzer DC. Lithium prophylaxis of corticotrophin-induced psychosis. JAMA 1979; 241(10): 1011–2PubMedCrossRef Falk WE, Mahnke MW, Poskanzer DC. Lithium prophylaxis of corticotrophin-induced psychosis. JAMA 1979; 241(10): 1011–2PubMedCrossRef
83.
84.
go back to reference Sabet-Sharghi F, Hutzler JC. Prophylaxis of steroid-induced psychiatric syndromes [letter]. Psychosomatics 1990; 31: 113–4PubMedCrossRef Sabet-Sharghi F, Hutzler JC. Prophylaxis of steroid-induced psychiatric syndromes [letter]. Psychosomatics 1990; 31: 113–4PubMedCrossRef
85.
go back to reference Saklad SR. Management of corticosteroid-induced psychosis with lithium. Clin Pharm 1987; 6: 186PubMed Saklad SR. Management of corticosteroid-induced psychosis with lithium. Clin Pharm 1987; 6: 186PubMed
86.
go back to reference Lynn DJ. Lithium in steroid-induced depression [letter]. Br J Psychiatry 1994; 166: 264CrossRef Lynn DJ. Lithium in steroid-induced depression [letter]. Br J Psychiatry 1994; 166: 264CrossRef
87.
go back to reference Olivesi A. Modified elimination of prednisolone in epileptic patients on carbamazepine monotherapy, and in women using low-dose oral contraceptives. Biomed Pharmacother 1986; 40: 301–8PubMed Olivesi A. Modified elimination of prednisolone in epileptic patients on carbamazepine monotherapy, and in women using low-dose oral contraceptives. Biomed Pharmacother 1986; 40: 301–8PubMed
88.
go back to reference Bloch M, Gur E, Shalev A. Chlorpromazine prophylaxis of steroid-induced psychosis. Gen Hosp Psychiatry 1994; 16: 42–4PubMedCrossRef Bloch M, Gur E, Shalev A. Chlorpromazine prophylaxis of steroid-induced psychosis. Gen Hosp Psychiatry 1994; 16: 42–4PubMedCrossRef
89.
go back to reference Abbas A, Stryra R. Valproate prophylaxis against steroid induced psychosis [letter]. Can J Psychiatry 1994; 39: 188–9PubMed Abbas A, Stryra R. Valproate prophylaxis against steroid induced psychosis [letter]. Can J Psychiatry 1994; 39: 188–9PubMed
90.
go back to reference Kahn D, Stevenson E, Douglas CJ. Effect of sodium valproate in three patients with organic brain syndromes. Am J Psychiatry 1988; 145: 1010–1PubMed Kahn D, Stevenson E, Douglas CJ. Effect of sodium valproate in three patients with organic brain syndromes. Am J Psychiatry 1988; 145: 1010–1PubMed
91.
go back to reference Brown ES, Khan DA, Suppes T. Treatment of corticosteroid-induced mood changes with olanzapine [letter]. Am J Psychiatry 1999; 156: 968PubMed Brown ES, Khan DA, Suppes T. Treatment of corticosteroid-induced mood changes with olanzapine [letter]. Am J Psychiatry 1999; 156: 968PubMed
92.
go back to reference Blazer DG, Petrie WM, Wilson WP. Affective psychosis following renal transplant. Dis Nerv Syst 1976; 37: 663–7PubMed Blazer DG, Petrie WM, Wilson WP. Affective psychosis following renal transplant. Dis Nerv Syst 1976; 37: 663–7PubMed
93.
go back to reference Terao T, Yoshimura R, Shiratuchi T, et al. Effects of lithium on steroid-induced depression. Biol Psychiatry 1997; 41: 1225–6PubMedCrossRef Terao T, Yoshimura R, Shiratuchi T, et al. Effects of lithium on steroid-induced depression. Biol Psychiatry 1997; 41: 1225–6PubMedCrossRef
94.
go back to reference Ismail K, Wessely S. Psychiatric complications of corticosteroid therapy. Br J Hosp Med 1995; 53: 495–9PubMed Ismail K, Wessely S. Psychiatric complications of corticosteroid therapy. Br J Hosp Med 1995; 53: 495–9PubMed
95.
go back to reference Bräunig P, Bleistein J, Rao ML. Suicidality and corticosteroid-induced psychosis [letter]. Biol Psychiatry 1989; 26: 209–10PubMedCrossRef Bräunig P, Bleistein J, Rao ML. Suicidality and corticosteroid-induced psychosis [letter]. Biol Psychiatry 1989; 26: 209–10PubMedCrossRef
96.
go back to reference Reckart MD, Eisendrath SJ. Exogenous corticosteroid effects on mood and cognition: case presentation. Int J Psychosom 1990; 37: 57–61PubMed Reckart MD, Eisendrath SJ. Exogenous corticosteroid effects on mood and cognition: case presentation. Int J Psychosom 1990; 37: 57–61PubMed
Metadata
Title
Corticosteroid-Induced Adverse Psychiatric Effects
Incidence, Diagnosis and Management
Authors
Assistant Professor Scott B. Patten
C. Ineke Neutel
Publication date
01-02-2000
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 2/2000
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-200022020-00004

Other articles of this Issue 2/2000

Drug Safety 2/2000 Go to the issue

Current Opinion

Iodine Supplementation